Carbamylated Erythropoietin

carbamylated erythropoietin · H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Carbamylated Erythropoietin, covering 2010-09-27 to 2016-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia [Phase 2]

See pricing